Coeptis Therapeutics Inc (COEP) Live Share Price, Invest From India

Coeptis Therapeutics Inc Stock Performance

as on April 23, 2026 at 2:59 am IST

Day's Low
Day's High
$14.76
Day's Price Range
$15.20
$15.18
2.77%
Downside
0.13%
Upside
52 Week's Low
52 Week's High
$6.26
52-Week Price Range
$21.41
$15.18
58.76%
Downside
41.04%
Upside

Coeptis Therapeutics Inc share price movements today

Previous Close: $14.93
Open: $15.20
Volume: 133.2K
Day's Low - High: $14.76 - $15.20
52 Week Low - High: $6.26 - $21.41

Coeptis Therapeutics Inc Historical Returns

1 Month Return: + 32.12 %
3 Month Return: + 2.86 %
1 Year Return: + 28.71 %
3 Year Return: -43.02 %
5 Year Return: 0 %

Coeptis Therapeutics Inc Stock Fundamentals & Key Indicators

Check Coeptis Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$96.7M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-11.9M

Revenue (TTM)

1.4M

Profit Margin

0.00%

Return On Equity TTM

-136.91%

Coeptis Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Coeptis Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Coeptis Therapeutics Inc	BUY	$96.7M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$41.2B	123.87%	131.81	8.45%
Vertex Pharmaceuticals Inc	BUY	$111.1B	102.14%	28.5	32.94%
BeiGene, Ltd.	NA	$36.5B	NA	128.25	5.37%
Regeneron Pharmaceuticals Inc	BUY	$79.2B	52.39%	18.05	31.41%

Stock Returns calculator for Coeptis Therapeutics Inc Stock including INR - Dollar returns

The Coeptis Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Coeptis Therapeutics Inc investment value today

Current value as on today

₹1,44,067

Returns

₹44,067

(+44.07%)

Returns from Coeptis Therapeutics Inc Stock

₹30,862 (+30.86%)

Dollar Impact

₹13,205 (+13.2%)

Analyst Recommendation on Coeptis Therapeutics Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Coeptis Therapeutics Inc. Average target price of $3

Coeptis Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Coeptis Therapeutics Inc.

What analysts predicted

-406%DOWNSIDE

Target Price

Current Price

$15.18

Analyzed by

7 Analysts

Target

$3.00

Coeptis Therapeutics Inc target price $3, a slight downside of -406% compared to current price of $15.18. According to 7 analysts rating.

Coeptis Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Coeptis Therapeutics Inc Stock has decreased by -75% in the last 30 days, reflecting a downward trend in search activity.

Time period: March 23, 2026 to April 22, 2026

Change:-75% versus previous 30 day period

Coeptis Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	1	-	1	-	1	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	-3
Operating Income	-7	-3	-2	-2	-2	-2	-4	-4	-2	-1
EBITDA	-7	-2	-2	-2	-1	-2	-3	-3	-2	-2
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-6	-3	-3	-3	-1	-3	-3	-4	-2	-1
Income Tax Expense	0	0	0	-1	-	-1	0	-	-2	-
Net Income	-6	-3	-3	-3	-1	-3	-3	-3	0	-1
Net Profit Margin	0.00%	-213.24%	0.00%	-202.11%	0.00%	-161.62%	-4863.27%	-1761.30%	-67.12%	-183.04%

Coeptis Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	-	-	-	1
Gross Profit	0	0	-1	-1	-1	-2
Operating Income	-6	-14	-34	-21	-10	-13
EBITDA	-8	-12	-36	-20	-9	-11
Interest Expense	0	0	0	0	0	0
Depreciation	0	0	1	1	1	1
Income Before Tax	-9	-13	-37	-21	-10	-12
Income Tax Expense	-2	0	3	3	-1	0
Net Income	-9	-13	-37	-21	-10	-11
Net Profit Margin	-29765.89%	-17932.37%	0.00%	0.00%	0.00%	-874.29%

Coeptis Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-3	-3	-3	-1	-3	-3	-4	-2	-1
Operating Cash Flow	-1	-1	-1	-1	-1	-2	-2	-2	-1
Investing Cash Flow	0	-	0	42	0	-	-	-	-
Financing Cash Flow	3	1	1	1	0	6	0	5	2
Change in Cash	1	0	0	0	0	3	-2	2	0

Coeptis Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2005	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	0	-1	0	-9	-13	-37	-37	-10	-11
Operating Cash Flow	0	0	0	-3	-4	-3	-3	-6	-8
Investing Cash Flow	-	0	1	-75	-1	-	-	-	-
Financing Cash Flow	0	0	0	2	8	5	5	5	13
Change in Cash	0	0	0	0	1	1	1	0	5

Global Institutional Holdings in Coeptis Therapeutics Inc

Funds	Holdings
Marshall Wace Asset Management Ltd	0.29%
Steward Partners Investment Advisory, LLC	0.04%
Steward Partners Investment Advisory, LLC	0.08%
Yorkville Advisors Global, LP	0%
Vanguard Group Inc	5.46%

See all

Insights on Coeptis Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, COEP stock has moved up by 14.9%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 47.4% return, outperforming this stock by 90.4%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 30.3% return, outperforming this stock by 1.6%

About Coeptis Therapeutics Inc

Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical and technology company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its therapeutic portfolio includes an allogeneic cellular immunotherapy platform; and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. The company's product pipeline consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; CD38-Diagnostic, an in vitro screening tool to analyze cancer patients if cancer patients might be appropriate candidates for anti-CD38 mAb therapy; and SNAP-CAR, a chimeric antigen receptor (CAR) therapy for treatment for cancer. In addition, the company offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.

Organisation	Coeptis Therapeutics Inc
Headquarters	105 Bradford Rd, Wexford, PA, United States, 15090
Industry	Biotechnology
CEO	Mr. David Mehalick
E-voting on shares	Click here to vote

Key Management of Coeptis Therapeutics Inc

Name	Title
Mr. David Mehalick	Co-Founder, Chairman of the Board, CEO & President
Ms. Christine Elise Sheehy	Co-Founder, VP of Compliance & Corporate Secretary
Mr. Daniel Alexander Yerace	Co-Founder, VP of Operations & Director
Mr. Brian Cogley M.B.A.	Chief Financial Officer

FAQs

What is Coeptis Therapeutics Inc share price today?

Coeptis Therapeutics Inc share price today is $15.18 as on April 22, 2026 at 9:29 pm IST. Coeptis Therapeutics Inc share today touched a day high of $15.2 and a low of $14.76.

What is the 52 week high and 52 week low for Coeptis Therapeutics Inc share?

Coeptis Therapeutics Inc share touched a 52 week high of $21.41 on November 26, 2025 and a 52 week low of $6.26 on April 25, 2025. Coeptis Therapeutics Inc stock price today i.e. April 22, 2026 at 9:29 pm IST is trending at $15.18,which is 29.10% down from its 52 week high and 142.49% up from its 52 week low.

What is Coeptis Therapeutics Inc's market capitalisation today?

Coeptis Therapeutics Inc market capitalisation is $0.00T as on April 22, 2026 at 9:29 pm IST.

How to invest in Coeptis Therapeutics Inc Stock (COEP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Coeptis Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Coeptis Therapeutics Inc Shares that will get you 0.0988 shares as per Coeptis Therapeutics Inc share price of $15.18 per share as on April 22, 2026 at 9:29 pm IST.

What is the minimum amount required to buy Coeptis Therapeutics Inc Stock (COEP) from India?

Indian investors can start investing in Coeptis Therapeutics Inc (COEP) shares with as little as ₹93.775 or $1 (as of April 22, 2026 at 9:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹937.75 in Coeptis Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on April 22, 2026 at 9:37 pm IST). Based on Coeptis Therapeutics Inc share’s latest price of $15.18 as on April 22, 2026 at 9:29 pm IST, you will get 0.6588 shares of Coeptis Therapeutics Inc. Learn more about fractional shares .